| [1] Casreo A, Del Corral J M, Gordaliza M, et al. Synthesis and cytotoxicity of podophyllotoxin analogues modified in the A ring[J]. Eur J Med Chem, 2003, 38(1): 65-74.[2] Liu Y Q, Yang L, Tian X. Podophyllotoxin: Current perspectives[J]. Curr Bioact Compd, 2007, 3(1): 37-66. [3] Sun Y J, Li Z L, Chen H, et al. Three new cytotoxic arytetralin lignans from Sinopodophyllum emodi[J]. Bioorg Med Chem Lett, 2011, 21(12): 3 794-3 797.[4] Wang Z Q, Hu H, Chen H X, et al. Antitumor agents. 124. New 4β-substituted aniline derivatives of 6,7-O, O-demethylene-4′-O-demethylpodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II[J]. J Med Chem, 1992, 35(5): 871-877.[5] Zhao C Q, Nagatsu A, Hatano K, et al. New lignan glycosides from Chinese medicinal plant, Sinopodophyllum emodi[J]. Chem Pharm Bull, 2003, 51(3): 255-261. |
